Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11851449 Heterocyclic amide compounds having an RORvt inhibitory action

Patent 11851449 was granted and assigned to Takeda Pharmaceutical Company on December, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Takeda Pharmaceutical Company

Current Assignee

Takeda Pharmaceutical Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118514490

Patent Inventor Names

Atsuko Ochida0

Shoji Fukumoto0

Yoshihide Tomata0

Naoki Ishii0

Mitsunori Kono0

Junya Shirai0

Tsuneo Oda0

Yusuke Sasaki0

...

Date of Patent

December 26, 2023

Patent Application Number

173161850

Date Filed

May 10, 2021

Patent Citations

‌

US Patent 7135498 Nitric oxide donors for inducing neurogenesis

‌

US Patent 9187453 Heterocyclic compound

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11851449 Heterocyclic amide compounds having an RORvt inhibitory action

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API